Myonectin modulates lipid and glucose metabolism, suppressing autophagy to overcome limitations of existing myokines lacking skeletal muscle specificity.
Segmenting targeting functions into small peptides improves tissue penetration while maintaining specific clusterin binding affinity.
Real-time allele-specific PCR identifies SAA1β/β homozygote biomarkers to detect liver cirrhosis risk factors.
ERK2 normalizes platelet protein expression levels, enabling accurate Alzheimer's diagnosis via non-invasive blood samples instead of cerebrospinal fluid.
Engineered anti-APOL1 antibodies with unique CDR sequences resolve cross-reactivity with APOL2 and APOL3, enabling precise detection of APOL1 on podocytes.